Volume 3, Issue 1 (January 2024)                   Health Science Monitor 2024, 3(1): 69-76 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Samarei R, Roshani A, Shokrani S. Headache as a sign of ear, nose, and throat diseases: evidence from a specialized clinic. Health Science Monitor 2024; 3 (1) :69-76
URL: http://hsm.umsu.ac.ir/article-1-117-en.html
Associate Professor of Rhinology, Department of Otorhinolaryngology and Head Neck Surgery, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran (Corresponding Author)
Abstract:   (690 Views)
Background & Aims: Headache has been a common problem for humans since ancient times. The aim of this study was to investigate the prevalence of ear, nose, and throat diseases in patients with headache.
Materials & Methods: In this descriptive cross-sectional study, we reviewed medical records of 100 patients presenting with headache to the ENT clinic of Imam Khomeini Hospital in Urmia, Iran, between 2019 and 2021. The type of headache (primary or secondary) was diagnosed based on medical history, clinical examinations, and paraclinical examinations (CT scan) and completion of a checklist for each patient. Chi-square and independent t-tests were used to analyze data. The p value < 0.05 was considered significant.
Results: Of 100 patients, 58 (58%) had primary headaches with a mean age of 1.72 ± 4.77 years, and 42 (42%) had secondary headaches with a mean age of 5.57 ± 1.43 years (p < 0.01). There was a significant difference in the type of headache and location of pain in patients except for the back of the head and the top of the head (p < 0.05). Of the 58 patients with primary headaches, 26 (44.8%), and of the 42 patients with secondary headaches, 10 (23.8%) woke up from sleep due to headache (p < 0.03). Of the 58 patients with primary headaches, 38 (65.5%), and of the 42 patients with secondary headaches, 12 (28.6%) had their headache worsened by light and noise (p < 0.001).
Conclusion: Of all patients, 42% had secondary headaches, which most commonly had symptoms of sinus pain. These patients were treated by an otolaryngologist. Patients with non-sinus headaches were referred to a neurologist.
Full-Text [PDF 322 kb]   (213 Downloads)    
Type of Study: Research | Subject: General
Received: 2023/04/23 | Accepted: 2023/10/23 | Published: 2024/01/6

References
1. Allais G, Chiarle G, Sinigaglia S, Airola G, Schiapparelli P, Benedetto C. Gender-related differences in migraine. Neurol Sci. 2020 Dec;41(Suppl 2):429-436. doi: 10.1007/s10072-020-04643-8. [DOI] [PMID] [PMCID]
2. Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;19(5):703-11. [DOI] [PMID]
3. Wang Z, Yang X, Zhao B, Li W. Primary headache disorders: From pathophysiology to neurostimulation therapies. Heliyon. 2023 Mar 23;9(4):e14786. doi: 10.1016/j.heliyon.2023.e14786 [DOI] [PMID] [PMCID]
4. Simon BJ, Errico JP, Raffle JT. Electrical and magnetic stimulators used to treat migraine/sinus headache, rhinitis, sinusitis, rhinosinusitis, and comorbid disorders. United States(US) Patent . 2019;10,279,163 B2. [Google Patents]
5. Carroll MP Jr, Bulkhi AA, Lockey RF. Rhinitis and Sinusitis. Asthma, Allergic and Immunologic Diseases During Pregnancy. 2018 Dec 30:61-86. doi: 10.1007/978-3-030-03395-8_5 [DOI]
6. Danishyar A, Ashurst JV. Acute Otitis Media. [Updated 2023 Apr 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470332/ [URL]
7. Suvas S. Role of Substance P Neuropeptide in Inflammation, Wound Healing, and Tissue Homeostasis. J Immunol. 2017 Sep 1;199(5):1543-1552. doi: 10.4049/jimmunol.1601751. [DOI] [PMID] [PMCID]
8. Shaikh A, Al Saey H, Ashkanani S, Alsulaiti M, Alduhirat E, Aljariri A, Abdulraheem M, Ganesan S. Higher incidence of headache in patients with intermittent mucosal contact points between the septum and lateral nasal wall. Laryngoscope Investig Otolaryngol. 2021 Jun 8;6(4):607-612. doi: 10.1002/lio2.577 [DOI] [PMID] [PMCID]
9. Ahmed F. Headache disorders: differentiating and managing the common subtypes. Br J Pain. 2012 Aug;6(3):124-32. doi: 10.1177/2049463712459691 [DOI] [PMID] [PMCID]
10. Steiner TJ, Jensen R, Katsarava Z, Linde M, MacGregor EA, Osipova V, Paemeleire K, Olesen J, Peters M, Martelletti P. Aids to management of headache disorders in primary care. The journal of headache and pain. 2019 Dec;20(1):1-52. [DOI] [PMID] [PMCID]
11. Kaur A, Singh A. Clinical study of headache in relation to sinusitis and its management. J Med Life. 2013; 6(4): 389-94. [PMCID]
12. Sabra O, Muhammad Ali M, Al Zayer M, Altuwaijri S. Frequency of migraine as a chief complaint in otolaryngology outpatient practice. Biomed Res Int. 2015;2015-21. [DOI] [PMID] [PMCID]
13. Benjamin T, Gillard D, Abouzari M, Djalilian HR, Sharon JD. Vestibular and auditory manifestations of migraine. Curr Opin Neurol. 2022 Feb 1;35(1):84-89. doi: 10.1097/WCO.0000000000001024 [DOI] [PMID] [PMCID]
14. Ali AH, Serhan OO, Alsharif MH, Elamin AY, Al-Ghamdi S, Aldossari KK, Alrudian N, Alajmi M, Alhariqi BA, Mokhatrish M, Palanivel V. Incidental detection of paranasal sinuses abnormalities on CT imaging of the head in Saudi adult population. Plos one. 2022 Sep 2;17(9):e0270764. [DOI] [PMID] [PMCID]
15. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine misdiagnosis as a sinusitis, a delay that can last for many years. J Headache Pain. 2013 Dec 12;14(1):97. doi: 10.1186/1129-2377-14-97 [DOI] [PMID] [PMCID]
16. Aydemir L, Doruk C, Çaytemel B, Şahin B, Şahin E, Çelik M, Çomoğlu Ş, Keleş Türel MN. Paranasal sinus volumes and headache: is there a relation?. European Archives of Oto-Rhino-Laryngology. 2019 Aug 1;276:2267-71. [DOI] [PMID]
17. Rains JC, Poceta JS. Sleep-related headaches. Neurologic Clinics. 2012; 30(4): 128-98. [DOI] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Health Science Monitor

Designed & Developed by : Yektaweb